Sundyota Numandis Probioceuticals Private Limited, a active private limited company, was established on 11 October 2011 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24230GJ2011PTC067414. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹2.41 Cr.
It upholds a compliant status. Employing 175 professional, Its leadership includes Bimal Indravadan Trivedi (Director), Ketul Rajendra Shah (Director), Dinesh Kumar Arora (Director). Past directors included Ketul Rajendra Shah, Smita Ravindra Bhatt, Mohit Tamhankar. It holds ₹121.28 Cr open charges and ₹9.83 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 701, Indraprasth Corporate, 100Ft Road Prahladnagar, Ahmedabad, Gujarat, 380015.
U24230GJ2011PTC067414
067414
11 October 2011
₹4.00 Cr
₹2.41 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Sundyota Numandis Probioceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bimal Indravadan Trivedi | Director | 11 Oct 2011 | Current |
| Ketul Rajendra Shah | Director | 19 Nov 2012 | Current |
| Dinesh Kumar Arora | Director | 11 Oct 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 19 Sep 2013 | Past |
| Pramod Abcsdd | Director | 28 Mar 2014 | Past |
| Pramod Abcsdd | Director | 14 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sundyota Numandis Probioceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.82% increase. The company also saw a substantial improvement in profitability, with a 22.54% increase in profit. The company's net worth Soared by an impressive increase of 25.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sundyota Numandis Probioceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,212,800,000.00
₹98,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Feb 2019 | State Bank Of India | ₹52.50 Cr | Open |
| 25 Jan 2019 | State Bank Of India | ₹51.62 Cr | Open |
| 25 Jan 2019 | State Bank Of India | ₹17.16 Cr | Open |
| 19 Feb 2019 | Idbi Bank Limited | ₹3.30 M | Satisfied |
| 25 May 2015 | Idbi Bank Limited | ₹9.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Sundyota Numandis Probioceuticals has a workforce of 175 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sundyota Numandis Probioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundyota Numandis Probioceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sundyota Numandis Probioceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Sundyota Numandis Probioceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
The activity A charge with State Bank Of India of Rs. 52.50 Cr registered on 22 Feb 2019 with Charge ID 100254825 was modified on 20 Nov 2024. was completed.
A charge with State Bank Of India of Rs. 51.62 Cr registered on 25 Jan 2019 with Charge ID 100246544 was modified on 18 Nov 2024. was recorded as a recent event.
Progress on A charge with State Bank Of India of Rs. 17.16 Cr registered on 25 Jan 2019 with Charge ID 100246548 was modified on 14 Aug 2024. was documented.
A charge registered on 19 Feb 2019 via Charge ID 100245319 with Idbi Bank Limited was fully satisfied on 05 Jul 2021. was recorded as a recent event.
India Business News: Ahmedabad, Apr 11 () City-based healthcare solutions firm Sundyota Numandis today announced the pan-India launch of its anti-diarrhea probiotic produc.
The CIN of Sundyota Numandis Probioceuticals Private Limited is U24230GJ2011PTC067414.
Sundyota Numandis Probioceuticals Private Limited is headquartered at 701, Indraprasth Corporate, 100Ft Road Prahladnagar, Ahmedabad, Gujarat, 380015.
Sundyota Numandis Probioceuticals Private Limited was incorporated on 11 October 2011.
The current directors of Sundyota Numandis Probioceuticals Private Limited are
The primary industry of Sundyota Numandis Probioceuticals Private Limited is Manufacturing.
Sundyota Numandis Probioceuticals Private Limited is unlisted.
The authorized capital of Sundyota Numandis Probioceuticals Private Limited is ₹4.00 Cr, and the paid-up capital is ₹2.41 Cr.
The compliance status of Sundyota Numandis Probioceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX